GUARDIGLI, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 3.545
AS - Asia 2.320
EU - Europa 1.088
SA - Sud America 417
AF - Africa 74
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.456
Nazione #
US - Stati Uniti d'America 3.444
SG - Singapore 940
CN - Cina 509
BR - Brasile 339
VN - Vietnam 286
IT - Italia 258
HK - Hong Kong 189
DE - Germania 187
UA - Ucraina 146
GB - Regno Unito 106
TR - Turchia 81
FI - Finlandia 78
FR - Francia 74
BD - Bangladesh 72
JP - Giappone 66
IN - India 56
SE - Svezia 46
CA - Canada 45
RU - Federazione Russa 45
MX - Messico 38
AR - Argentina 31
NL - Olanda 28
ZA - Sudafrica 25
ID - Indonesia 23
PL - Polonia 23
IQ - Iraq 21
ES - Italia 20
CO - Colombia 15
LT - Lituania 15
UZ - Uzbekistan 11
KE - Kenya 10
MA - Marocco 10
PK - Pakistan 10
AT - Austria 9
BE - Belgio 9
EG - Egitto 9
MY - Malesia 9
PH - Filippine 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
DK - Danimarca 7
SA - Arabia Saudita 7
BO - Bolivia 6
EC - Ecuador 6
TN - Tunisia 6
IE - Irlanda 5
AL - Albania 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
PY - Paraguay 4
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
JM - Giamaica 3
PE - Perù 3
SV - El Salvador 3
BW - Botswana 2
HU - Ungheria 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
Totale 7.448
Città #
Singapore 587
Ashburn 518
San Jose 284
Woodbridge 210
Santa Clara 198
Hong Kong 184
Chandler 174
Fairfield 167
Jacksonville 151
Beijing 139
Houston 130
New York 105
Ho Chi Minh City 93
Ann Arbor 88
Hanoi 76
Wilmington 76
Munich 75
Los Angeles 74
Seattle 71
Tokyo 64
Dallas 61
Nanjing 52
Cambridge 46
Princeton 44
Izmir 43
Lauterbourg 42
São Paulo 39
Helsinki 32
Milan 32
Shanghai 32
Boardman 28
Mexico City 27
San Diego 27
Bologna 26
Orem 25
Council Bluffs 24
Ferrara 24
Denver 22
Buffalo 21
London 21
Warsaw 20
Atlanta 19
Bremen 19
Chicago 19
Brooklyn 18
Stockholm 17
Da Nang 16
The Dalles 16
Turku 16
Phoenix 15
Jakarta 14
Johannesburg 14
Shenyang 14
Toronto 14
Chennai 13
Hefei 13
Montreal 13
Rome 13
Naples 12
Falls Church 11
Tashkent 11
Tianjin 11
Boston 9
Düsseldorf 9
Haiphong 9
Nairobi 9
New Delhi 9
Poplar 9
Rio de Janeiro 9
San Francisco 9
Brussels 8
Changsha 8
Dhaka 8
Jiaxing 8
Moscow 8
Nanchang 8
Amsterdam 7
Belo Horizonte 7
Dearborn 7
Hebei 7
Nuremberg 7
Thái Nguyên 7
Acireale 6
Baghdad 6
Cairo 6
Columbus 6
Falkenstein 6
Goiânia 6
Kunming 6
Manchester 6
Ninh Bình 6
Odense 6
Redwood City 6
Sydney 6
Tampa 6
Addison 5
Bogotá 5
City of London 5
Erbil 5
Fortaleza 5
Totale 4.725
Nome #
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 250
Reperfusion Damage - A Story of Success, Failure, and Hope 234
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 209
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 204
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 202
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 201
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 194
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 191
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 184
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 180
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 179
Bradykinin and coronary artery disease 176
A modern fairy tale 175
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 174
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 167
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 166
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 165
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 163
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 162
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 160
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 160
Angiotensin II overproduction: enemy of the vessel wall 159
Multimodality imaging in acromegalic cardiomiopathy: a case report 155
Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna [Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 155
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 155
The heart rate story 154
Oxidative stress during myocardial ischaemia and heart failure 153
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 153
Tirofiban: A critical reappraisal of the clinical use, recent developments and future perspectives 150
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 150
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 146
Ferrara VI 143
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score 142
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 142
Safety and efficacy of new-generation coronary bioresorbable scaffolds 141
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 129
FERRARA: CITTÀ DELLA PREVENZIONE 128
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 127
LEFT VENTRICULAR REMODELLING AT THE LIMITS 117
Ferrara II 113
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 109
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 103
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 100
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 98
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 97
One-year outcome of elderly patients with endocarditis: a retrospective observational study 92
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 87
The future of cardiovascular prevention: between fiction and reality 74
null 61
Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy 59
Cardiovascular prevention: sometimes dreams can come true 45
Physical activity and cardiac rehabilitation after myocardial infarction: the risk of obtaining large benefits 11
Totale 7.544
Categoria #
all - tutte 34.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 531
Totale 35.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022361 11 43 24 13 18 18 15 21 14 25 35 124
2022/2023423 40 10 16 44 84 67 20 41 54 6 34 7
2023/2024282 19 37 10 4 13 47 21 23 5 8 14 81
2024/20251.326 23 35 87 71 162 127 44 53 270 126 177 151
2025/20263.741 397 155 276 475 576 259 386 236 336 400 226 19
Totale 7.544